630
Views
16
CrossRef citations to date
0
Altmetric
Cardiovascular: Original articles

Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis

&
Pages 1-10 | Accepted 04 Sep 2013, Published online: 01 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mario J.N.M. Ouwens, Jos Nauta, Jean-Claude Ansquer & Stefan Driessen. (2015) Systematic literature review and meta-analysis of dual therapy with fenofibrate or fenofibric acid and a statin versus a double or equivalent dose of statin monotherapy. Current Medical Research and Opinion 31:12, pages 2273-2285.
Read now
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher & Paola Loria. (2015) Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 9:5, pages 629-650.
Read now

Articles from other publishers (14)

Lijing Du, Qian Wang, Shuai Ji, Yuanfang Sun, Wenjing Huang, Yiping Zhang, Shasha Li, Shikai Yan & Huizi Jin. (2022) Metabolomic and Microbial Remodeling by Shanmei Capsule Improves Hyperlipidemia in High Fat Food-Induced Mice. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Ping Yu, Wenjing Liu, Jinghui Ren, Yingying Wang, Yao Ning, Mingqi Huang, Xinyi Hu, Lili Wei, Min Ji & Jin Cai. (2019) Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2168-2172.
Crossref
Sheng Wang & Xin-jian Qiu. (2019) The efficacy of Xue Fu Zhu Yu prescription for hyperlipidemia: A meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 43, pages 218-226.
Crossref
Yu Fan, Xin Jin, Changfeng Man & Dandan Gong. (2018) Does Adjuvant Treatment With Ginkgo Biloba to Statins Have Additional Benefits in Patients With Dyslipidemia?. Frontiers in Pharmacology 9.
Crossref
Krzysztof Dyrbuś, Tadeusz Osadnik, Piotr Desperak, Aneta Desperak, Mariusz Gąsior & Maciej Banach. (2018) Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry. Pharmacological Research 132, pages 204-210.
Crossref
Giovanni Ciccarelli, Saverio D’Elia, Michele De Paulis, Paolo Golino & Giovanni Cimmino. (2018) Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies. Diseases 6:1, pages 22.
Crossref
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer & Salman Azhar. (2017) PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. Future Cardiology 13:3, pages 259-278.
Crossref
Yongbin Lu, Zhiyuan Cheng, Yaxue Zhao, Xiaoyu Chang, Cynthia Chan, Yana Bai & Ning Cheng. (2016) Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis. Atherosclerosis 254, pages 215-227.
Crossref
François Laliberté, Michel Cloutier, Concetta Crivera, Winnie W. Nelson, William H. Olson, Jeffrey Schein, Julie Vanderpoel, Guillaume Germain & Patrick Lefebvre. (2015) Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users. Advances in Therapy 32:3, pages 216-227.
Crossref
Rajesh Munglani & Arun Bhaskar. (2015) Pain and Suffering in Cancer Patients. Modern Believing 56:2, pages 145-162.
Crossref
Geoff Appelboom, Elvis Camacho, Mickey E Abraham, Samuel S Bruce, Emmanuel LP Dumont, Brad E Zacharia, Randy D’Amico, Justin Slomian, Jean Yves Reginster, Olivier Bruyère & E Sander Connolly. (2014) Smart wearable body sensors for patient self-assessment and monitoring. Archives of Public Health 72:1.
Crossref
E. Behling-Kelly. (2014) Serum Lipoprotein Changes in Dogs with Renal Disease. Journal of Veterinary Internal Medicine 28:6, pages 1692-1698.
Crossref
Yunes Panahi, Nahid Khalili, Mahboobeh Sadat Hosseini, Mohammad Abbasinazari & Amirhossein Sahebkar. (2014) Lipid-modifying effects of adjunctive therapy with curcuminoids?piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies in Medicine 22:5, pages 851-857.
Crossref
A. Sahebkar & G. F. Watts. (2014) Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster. Diabetes, Obesity and Metabolism 16:9, pages 780-792.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.